𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Overexpression of fatty acid synthase in human urinary bladder cancer and combined expression of the synthase and Ki-67 as a predictor of prognosis of cancer patients

✍ Scribed by Takashi Sugino; Keiichi Baba; Nobuo Hoshi; Ken Aikawa; Osamu Yamaguchi; Toshimitsu Suzuki

Book ID
106239132
Publisher
Springer
Year
2011
Tongue
English
Weight
441 KB
Volume
44
Category
Article
ISSN
0918-4287

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expression of fatty acid synthase (FAS)
Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients
✍ Piero L. Alo; Paolo Visca; Adele Marci; Antonella Mangoni; Claudio Botti; Ugo Di πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 859 KB

## BACKGROUND. Fatty acid synthase (FAS) is a molecule found in tumor cells from breast carcinomas of patients whose prognosis is very poor. Recently, this molecule has been identified as the key enzyme in fatty acid biosynthesis. This study was done to test the strength of FAS as a prognostic ind

Expression of the lipogenic enzyme fatty
Expression of the lipogenic enzyme fatty acid synthase (FAS) as a predictor of poor outcome in nephroblastoma: An interinstitutional study
✍ Camassei, Francesca Diomedi ;Jenkner, Alessandro ;RavΓ , Lucilla ;Bosman, Cesare πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 219 KB

## Abstract ## Background Treatment of nephroblastoma (Wilms tumor) has presently achieved a greater than 80% cure rate. Pathologic stage and grade are considered the most reliable prognostic parameters, but other biologic factors are under study in order to improve patient stratification into ris

In support of fatty acid synthase (FAS)
In support of fatty acid synthase (FAS) as a metabolic oncogene: Extracellular acidosis acts in an epigenetic fashion activating FAS gene expression in cancer cells
✍ Javier A. Menendez; Josiah P. Decker; Ruth Lupu πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 122 KB

## Abstract Relatively little information exists on the ultimate molecular mechanisms by which the lipogenic enzyme Fatty Acid Synthase (FAS) is differentially overexpressed in a biologically aggressive subset of human malignancies. Since the microenvironment of solid tumors contains regions of poo

Does endogenous fatty acid metabolism al
Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1Ξ± (HIF-1Ξ±)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene
✍ Javier A. Menendez; Luciano Vellon; Bharvi P. Oza; Ruth Lupu πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 249 KB πŸ‘ 1 views

## Abstract Her‐2/__neu__ (__erb__B‐2) oncogene overexpression is associated with increased tumor progression and metastasis. Fatty acid synthase (FAS), the key lipogenic enzyme responsible for the endogenous synthesis of fatty acids, has been shown to be one of the genes regulated by Her‐2/__neu__

Human hepatic and renal microsomes, cyto
Human hepatic and renal microsomes, cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer
✍ Marie StiborovΓ‘; Eva Frei; Petr Hodek; Manfred Wiessler; Heinz H. Schmeiser πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 139 KB

## Abstract Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been associated with the development of urothelial cancer in humans. Understanding which human enzymes are involved in AA activation and/or detoxication is important in the assessment of an individual's suscep